Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baigent

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Internal Medicine|March 27, 2010
Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older menJ R Emberson, R Haynes, T Dasgupta, et al.
Lancet (London, England)|January 15, 2008
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, P M Kearney, L Blackwell, et al.
BMJ (Clinical Research Ed.)|September 14, 1996
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trialsR Collins, S MacMahon, M Flather, et al.
Lancet (London, England)|May 22, 2012
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, B Mihaylova, J Emberson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2001
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairmentM J Landray, J Thambyrajah, F J McGlynn, et al.
BMJ (Clinical Research Ed.)|October 5, 2013
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials, T Ninomiya, V Perkovic, et al.
Lancet (London, England)|October 11, 2005
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsC Baigent, A Keech, P M Kearney, et al.
Lancet (London, England)|November 12, 2010
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, C Baigent, L Blackwell, et al.
BMC Nephrology|May 3, 2017
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal ProtectionC Reith, N Staplin, W G Herrington, et al.
Thrombosis and Haemostasis|May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart DiseaseR De Caterina, S Husted, L Wallentin, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Internal Medicine|March 27, 2010
Cystatin C and risk of vascular and nonvascular mortality: a prospective cohort study of older menJ R Emberson, R Haynes, T Dasgupta, et al.
Lancet (London, England)|January 15, 2008
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, P M Kearney, L Blackwell, et al.
BMJ (Clinical Research Ed.)|September 14, 1996
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trialsR Collins, S MacMahon, M Flather, et al.
Lancet (London, England)|May 22, 2012
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, B Mihaylova, J Emberson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2001
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairmentM J Landray, J Thambyrajah, F J McGlynn, et al.
BMJ (Clinical Research Ed.)|October 5, 2013
Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials, T Ninomiya, V Perkovic, et al.
Lancet (London, England)|October 11, 2005
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsC Baigent, A Keech, P M Kearney, et al.
Lancet (London, England)|November 12, 2010
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, C Baigent, L Blackwell, et al.
BMC Nephrology|May 3, 2017
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal ProtectionC Reith, N Staplin, W G Herrington, et al.
Thrombosis and Haemostasis|May 3, 2013
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart DiseaseR De Caterina, S Husted, L Wallentin, et al.
Pageof 4